Showing results (461-470 of 31,421) with videos related to
Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|September 1, 1986
Effect of antibiotics on adherence of Haemophilus influenzae type bJ R Gilsdorf, J M JespersonAntimicrobial Agents and Chemotherapy|September 1, 1986
7 alpha-formylamino substituent confers beta-lactamase-inactivating potency on 1-oxacephalosporinsK Murakami, M Doi, T YoshidaAntimicrobial Agents and Chemotherapy|January 18, 2022
Molecular Characterization of Mycobacterium ulcerans DNA Gyrase and Identification of Mutations Reducing Susceptibility to Quinolones In VitroHyun Kim, Shigetarou Mori, Tsuyoshi Kenri, et al.Antimicrobial Agents and Chemotherapy|January 18, 2022
Transcriptomics Reveals How Minocycline-Colistin Synergy Overcomes Antibiotic Resistance in Multidrug-Resistant Klebsiella pneumoniaeThea Brennan-Krohn, Alexandra Grote, Shade Rodriguez, et al.Antimicrobial Agents and Chemotherapy|January 10, 2022
Azole-Resistant Alleles of ERG11 in Candida glabrata Trigger Activation of the Pdr1 and Upc2A Transcription FactorsBao Gia Vu, W Scott Moye-RowleyAntimicrobial Agents and Chemotherapy|January 10, 2022
Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Acinetobacter baumannii InfectionHaley J Appaneal, Vrishali V Lopes, Kerry L LaPlante, et al.Antimicrobial Agents and Chemotherapy|January 10, 2022
A Humanized Monoclonal Antibody Potentiates Killing of Diverse Biofilm-Forming Respiratory Tract Pathogens by AntibioticsNikola Kurbatfinski, Steven D Goodman, Lauren O BakaletzAntimicrobial Agents and Chemotherapy|August 1, 1987
Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillinC C Sanders, W E Sanders, R V Goering, et al.Antimicrobial Agents and Chemotherapy|December 6, 2021
Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of mef(C)-mph(G) GenesEtienne Bizot, Aurélie Cointe, Philippe Bidet, et al.Antimicrobial Agents and Chemotherapy|December 6, 2021
Ponatinib, Lestaurtinib, and mTOR/PI3K Inhibitors Are Promising Repurposing Candidates against Entamoeba histolyticaMonica M Kangussu-Marcolino, Upinder SinghPageof 3,143